D-1321-2019 Class I Terminated
FDA drug recall D-1321-2019 was initiated by Stiff Boy LLC on May 6, 2019 and is designated Class I. Reason for recall: Marketed without an Approved NDA/ANDA: The Beast contains undeclared sildenafil which was discovered through FDA analysis. The recall status is terminated (terminated Sep 16, 2025). Affected quantity: 1000 boxes.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 5, 2019
- Initiation Date
- May 6, 2019
- Termination Date
- Sep 16, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1000 boxes
Product description
The Beast, The Beast can be taken under the situation of Heart disease and even after drinking, 4600 mg X 4 Capsules per packet.
Reason for recall
Marketed without an Approved NDA/ANDA: The Beast contains undeclared sildenafil which was discovered through FDA analysis.
Distribution pattern
Nationwide
Code information
All lots
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1321-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026